305 related articles for article (PubMed ID: 17510401)
1. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
[TBL] [Abstract][Full Text] [Related]
2. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
[TBL] [Abstract][Full Text] [Related]
3. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms.
Ruas M; Gregory F; Jones R; Poolman R; Starborg M; Rowe J; Brookes S; Peters G
Mol Cell Biol; 2007 Jun; 27(12):4273-82. PubMed ID: 17420273
[TBL] [Abstract][Full Text] [Related]
4. Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence.
Gagrica S; Brookes S; Anderton E; Rowe J; Peters G
Cancer Res; 2012 Jan; 72(1):165-75. PubMed ID: 22080569
[TBL] [Abstract][Full Text] [Related]
5. The COOH terminus of p18INK4C distinguishes function from p16INK4A.
Gump J; Turner S; Koh J
Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797
[TBL] [Abstract][Full Text] [Related]
6. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
7. p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.
Cen L; Carlson BL; Schroeder MA; Ostrem JL; Kitange GJ; Mladek AC; Fink SR; Decker PA; Wu W; Kim JS; Waldman T; Jenkins RB; Sarkaria JN
Neuro Oncol; 2012 Jul; 14(7):870-81. PubMed ID: 22711607
[TBL] [Abstract][Full Text] [Related]
8. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
9. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Carbone CJ; Graña X; Reddy EP; Haines DS
Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
[TBL] [Abstract][Full Text] [Related]
10. Expression of p18(INK4C) is down-regulated in human pituitary adenomas.
Hossain MG; Iwata T; Mizusawa N; Qian ZR; Shima SW; Okutsu T; Yamada S; Sano T; Yoshimoto K
Endocr Pathol; 2009; 20(2):114-21. PubMed ID: 19401813
[TBL] [Abstract][Full Text] [Related]
11. p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis.
Buchold GM; Magyar PL; Arumugam R; Lee MM; O'Brien DA
Mol Reprod Dev; 2007 Aug; 74(8):997-1007. PubMed ID: 17342741
[TBL] [Abstract][Full Text] [Related]
12. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.
Baughn LB; Di Liberto M; Wu K; Toogood PL; Louie T; Gottschalk R; Niesvizky R; Cho H; Ely S; Moore MA; Chen-Kiang S
Cancer Res; 2006 Aug; 66(15):7661-7. PubMed ID: 16885367
[TBL] [Abstract][Full Text] [Related]
13. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.
Kovalev GI; Franklin DS; Coffield VM; Xiong Y; Su L
J Immunol; 2001 Sep; 167(6):3285-92. PubMed ID: 11544316
[TBL] [Abstract][Full Text] [Related]
14. Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development.
Wiedemeyer R; Brennan C; Heffernan TP; Xiao Y; Mahoney J; Protopopov A; Zheng H; Bignell G; Furnari F; Cavenee WK; Hahn WC; Ichimura K; Collins VP; Chu GC; Stratton MR; Ligon KL; Futreal PA; Chin L
Cancer Cell; 2008 Apr; 13(4):355-64. PubMed ID: 18394558
[TBL] [Abstract][Full Text] [Related]
15. Erythroid Kruppel-like factor regulates the G1 cyclin dependent kinase inhibitor p18INK4c.
Tallack MR; Keys JR; Perkins AC
J Mol Biol; 2007 Jun; 369(2):313-21. PubMed ID: 17442339
[TBL] [Abstract][Full Text] [Related]
16. A Conserved Gammaherpesvirus Cyclin Specifically Bypasses Host p18(INK4c) To Promote Reactivation from Latency.
Williams LM; Niemeyer BF; Franklin DS; Clambey ET; van Dyk LF
J Virol; 2015 Nov; 89(21):10821-31. PubMed ID: 26292318
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise.
Nuzzo AM; Giuffrida D; Masturzo B; Mele P; Piccoli E; Eva C; Todros T; Rolfo A
Cell Cycle; 2017 Jan; 16(2):200-212. PubMed ID: 27937072
[TBL] [Abstract][Full Text] [Related]
18. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
[TBL] [Abstract][Full Text] [Related]
19. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
[TBL] [Abstract][Full Text] [Related]
20. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]